Ophthalmology

1 Credit / Cardiology, Neurology

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Ophthalmology/Optometry

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credit / Ophthalmology/Optometry

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

1.5 Credit / Ophthalmology/Optometry

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

More News

September 27th 2023

AI Effective in Screening for Referable Diabetic Retinopathy

In a real-world setting, artificial intelligence (AI) proved to be effective in screening for referable diabetic retinopathy.

September 21st 2023

Study Confirms Retinal Structural Associations Between Retinitis Pigmentosa, Macular Edema

Researchers also suggest potential new genetic associations with macular edema, which warrant further research.

September 18th 2023

Differences in Ophthalmology Residents’ Medical Knowledge Ratings Could Indicate Gender Disparities

Although major gender bias on the national level was not found, differences in medical knowledge (MK) ratings could be an indicator of gender bias in ophthalmology education.

September 11th 2023

Drug Manufacturer Payments Associated With Prescribing Higher-Cost Therapies for ARMD

Higher-cost therapies for age-related macular edema (ARMD) were significantly more likely to be prescribed by ophthalmologists accepting manufacturer payments.

September 5th 2023

E-Cigarette, Cigarette Users Have Higher Likelihood of Ocular Symptoms

Severe and frequent ocular symptoms were more likely in adolescents and young adults who used e-cigarettes and cigarettes.

September 3rd 2023

Macular Thickness Maps Effective Tools in Remote Monitoring of eAMD

Recurrent exudations in patients with exudative age-related macular degeneration (eAMD) can be sufficiently monitored with macular thickness maps alone.

August 31st 2023

FDA Approves Higher-Dose Version of Aflibercept

Skylar Jeremias

The FDA approved a higher dosage of aflibercept (Eylea) for the treatment of age-related macular degeneration, macular edema, and diabetic retinopathy.

August 21st 2023

Polygenic Risk Score Identifies Individuals at Higher Risk of POAG

Individuals with a higher risk of primary open-angle glaucoma (POAG) could be identified using a polygenic risk score, recent study found.

August 17th 2023

Vision Testing Lowest in Adolescents Without Insurance

A recent study found that children who had private insurance had a higher probability of vision testing compared with uninsured and publicly insured children.

August 14th 2023

Leakage Index Associated With Macular Edema Severity

Patients with nonischemic branch retinal vein occlusion had their macular edema severity associated with leakage index.

August 7th 2023

FDA Approves New Treatment for Geographic Atrophy

The FDA approved the usage of Izervay (avacincaptad pegol) for the treatment of geographic atrophy secondary to age-related macular degeneration.

August 4th 2023

ASRS 2023: Intended vs Actual Treatment Intervals Between Intravitreal Anti-VEGF Injections: Effects of Treatment Days

Lynda Charters

In the study, researchers found that nearly one-quarter of anti-VEGF injections were received at least 1 week later than intended.

August 2nd 2023

Smokeless Tobacco More Likely to Cause AMD, Study Suggests

Adults who used smokeless tobacco products were more likely to have age-related macular degeneration (AMD) compared with cigarette smokers.

July 27th 2023

Exposure to Statins Not Related to Increased Risk of OAG

A study conducted in Japan found that short-term exposure to statins was not associated with an increased risk of open-angle glaucoma (OAG) in a population with dyslipidemia.

July 24th 2023

Expansion of Laser Eye Surgery Not Associated With Shorter Travel Times for Care

Having optometrists perform laser eye surgery was not found to lead to a meaningful increase in nearby health care professionals for the population.

July 21st 2023

Low Vision Rehabilitation Recommended for Patients With ARMD

Patients with age-related macular degeneration (ARMD) with geographic atrophy should use low vision aids.

July 17th 2023

Atropine 0.01% Not Associated With Slowing Myopia Progression

A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression.

July 12th 2023

In Vitreoretinal Subspecialty, Men Have More Publications, Occupy Higher Academic Positions

A search of residency programs in the United States found that women made up about a quarter of all academic vitreoretinal specialists.

July 10th 2023

Novel Smartphone App Effective in Assessing Pediatric Ophthalmology

A smartphone app was found to be useful and reliable by clinicians when testing vision for children during the COVID-19 pandemic.

July 5th 2023

Retinopathy of Prematurity Risk Linked to Parenteral Nutrition Duration

Infants who received parenteral nutrition for at least 14 days had a higher risk of retinopathy of prematurity and receiving treatment.

June 26th 2023

Prevalence of Eye Disease Related to Diabetes Remains High in United States

A new study estimated that 9.60 million people are living with diabetic retinopathy and 1.84 million people are living with vision-threatening diabetic retinopathy in the United States.

June 26th 2023

Dr Byron Lam Highlights Treatments in the Pipeline for Inherited Retinal Disease

Gene therapy is only one exciting area of treatments in the pipeline to potentially treat inherited retinal disease, said Byron L. Lam, MD, professor of ophthalmology, University of Miami Miller School of Medicine's Bascom Palmer Eye Institute.

June 19th 2023

Microbial Keratitis Severity Associated With Patient Characteristics, Location

Social risk factors, such as patient characteristics and where they live, informed the severity of microbial keratitis in a sample of patients.

June 13th 2023

Artificial Intelligence Has Potential to Estimate BCVA in Patients With DME

Fundus photographs of eyes with diabetic macular edema (DME) could be used to estimate best-corrected visual acuity (BCVA) when artificial intelligence examines the pictures.

June 11th 2023

Dr Byron Lam Reviews Current Treatments and Therapies in the Pipeline for Inherited Retinal Disease

The most exciting treatment for inherited retinal disease was approved in 2017, but there are many novel treatments in phase 2 or phase 3 trials at this point, said Byron L. Lam, MD, professor of ophthalmology, University of Miami Miller School of Medicine's Bascom Palmer Eye Institute.

June 9th 2023

Low-dose Atropine for Pediatric Myopia Progression Found Effective in Phase 3 Trial

Childhood myopia progression could be treated with low-dose atropine due to the safety and efficacy displayed in this study.

May 30th 2023

Infliximab, Adalimumab Have Similar Efficacy in Patients With Noninfectious Uveitis

Adalimumab had a slight advantage over infliximab in terms of adverse events when used to treat patients with noninfectious uveitis (NIU).

May 29th 2023

Dr Byron Lam Discusses Impact on SES Factors on Glaucoma Screening Follow-up

Insurance is by far the most important factor of whether patients followed up with treatment after getting screened for glaucoma, said Byron L. Lam, MD, professor of ophthalmology, University of Miami Miller School of Medicine's Bascom Palmer Eye Institute.

May 23rd 2023

Failure to Attend Follow-up Is the Main Reason for Discontinuation of Amblyopia Therapy

About 69% of pediatric patients had discontinued amblyopia therapy during COVID-19 even as their parents reported that adherence was good.

May 21st 2023

Dr Charles Wykoff: Gene Therapy for Wet AMD Would Be a Tremendous Opportunity